MolNFT v1 · #183652 · protein
Trmb complex with SAM
7NYB · TRNA (guanine-N(7)-)-methyltransferase: “Trmb complex with SAM”. X-ray diffraction, 1 ligand (SAM), 5 pockets (best druggability 0.59). MolNFT v1 #183652 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 7NYB
- Type
- protein
- Length
- 410 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- TRNA (guanine-N(7)-)-methyltransferase
- EC
- 2.1.1.33
- UniProt
- O34522
- Ligands
- SAM
- Pockets
- 5 · best druggability 0.59
Structure
x-ray diffraction · 2 distinct chains · 42% helix, 19% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | TRNA (guanine-N(7)-)-methyltransferase (EC 2.1.1.33) | protein | 206 | 42% helix, 19% strand | O34522 |
| B | TRNA (guanine-N(7)-)-methyltransferase (EC 2.1.1.33) | protein | 204 | 42% helix, 19% strand | O34522 |
Ligands and binding sites
- SAM · S-adenosylmethionine · ligand · 2 copies · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 223 | 0.59 | 0.80 | 29 | SAM |
| 2 | 228 | 0.59 | 0.80 | 30 | SAM |
| 3 | 90 | 0.42 | 0.79 | 23 | empty |
| 4 | 77 | 0.39 | 0.78 | 22 | empty |
| 5 | 64 | 0.30 | 0.74 | 18 | empty |
Interfaces
1 interface between chains.
- A–B · 832 Ų buried · 17 hydrogen bonds · protein-protein
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt O34522
- Elsewhere: RCSB PDB 7NYB · PDBe 7NYB · UniProt O34522
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.